XML 45 R36.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Grant Agreements - Additional Information (Details) - USD ($) $ / shares in Units, $ in Thousands |  | 3 Months Ended | 9 Months Ended |
--- | --- | --- | --- | ---
Jan. 13, 2022 | Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | Dec. 31, 2021
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] |  |  |  |  |  |
Accrued and other liabilities |  | $ 282,616 |  | $ 282,616 |  | $ 236,512
Grant Revenue |  |  |  |  |  |
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] |  |  |  |  |  |
Revenue from grants |  | 3,125 | $ 903 | 7,704 | $ 5,356 |
Human Immunodeficiency Virus ('HIV') Grant | Maximum |  |  |  |  |  |
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] |  |  |  |  |  |
Grant awarded amount. maximum |  | 55,700 |  | 55,700 |  |
Vaccinal Antibody Grant | Grant Revenue |  |  |  |  |  |
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] |  |  |  |  |  |
Revenue from grants |  | 2,800 | $ 900 | 7,400 | $ 5,200 |
Vaccinal Antibody Grant | Bill And Melinda Gates Foundation |  |  |  |  |  |
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] |  |  |  |  |  |
Deferred revenue |  | 24,300 |  | 24,300 |  | 6,900
Common Stock, Shares Purchased | 881,365 |  |  |  |  |
Common Stock, Shares Purchased, Share Price | $ 45.38 |  |  |  |  |
Common Stock, Shares Purchased , Aggregate Purchase Price | $ 40,000 |  |  |  |  |
Common stock, shares issued, fair market value | $ 28,500 |  |  |  |  |
Closing stock price | $ 37.65 |  |  |  |  |
Underlying shares, Premium received | $ 11,300 |  |  |  |  |
Accrued and other liabilities |  | $ 0 |  | 0 |  | $ 1,800
BARDA |  |  |  |  |  |
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] |  |  |  |  |  |
Potential maximum amount of grant |  |  |  | 1,000,000 |  |
Maximum amount of grant during the base period |  |  |  | $ 55,000 |  |

X
- Definition Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other. + References No definition available. + Details
Name: | us-gaap_AccruedLiabilitiesAndOtherLiabilities
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of deferred income excluding obligation to transfer product and service to customer for which consideration has been received or is receivable. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section 25 -Paragraph 2 -URI https://asc.fasb.org/extlink&oid=28183603&loc=d3e692-112598 + Details
Name: | us-gaap_DeferredIncome
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount of revenue that is not accounted for under Topic 606. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(1)) -URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227 + Details
Name: | us-gaap_RevenueNotFromContractWithCustomer
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Closing stock price + References No definition available. + Details
Name: | vir_ClosingStockPrice
Namespace Prefix: | vir_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Common stock, shares issued, fair market value + References No definition available. + Details
Name: | vir_CommonStockSharesIssuedFairMarketValue
Namespace Prefix: | vir_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Common Stock, Shares Purchased + References No definition available. + Details
Name: | vir_CommonStockSharesPurchased
Namespace Prefix: | vir_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Common Stock, Shares Purchased , Aggregate Purchase Price + References No definition available. + Details
Name: | vir_CommonStockSharesPurchasedAggregatePurchasePrice
Namespace Prefix: | vir_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Common Stock, Shares Purchased, Share Price + References No definition available. + Details
Name: | vir_CommonStockSharesPurchasedSharePrice
Namespace Prefix: | vir_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Maximum grant awarded amount. + References No definition available. + Details
Name: | vir_GrantAwardedAmountMaximum
Namespace Prefix: | vir_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Maximum Amount Grant Aggregate + References No definition available. + Details
Name: | vir_MaximumAmountGrantAggregate
Namespace Prefix: | vir_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Maximum Amount Grant Base Period + References No definition available. + Details
Name: | vir_MaximumAmountGrantBasePeriod
Namespace Prefix: | vir_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Underlying shares, Premium received + References No definition available. + Details
Name: | vir_UnderlyingSharesPremiumReceived
Namespace Prefix: | vir_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | srt_ProductOrServiceAxis=us-gaap_GrantMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=vir_HumanImmunodeficiencyVirusGrantMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=vir_VaccinalAntibodyGrantMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=vir_BillAndMelindaGatesFoundationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=vir_BiomedicalAdvancedResearchAndDevelopmentAuthorityMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |